Philip Wagenheim's most recent trade in Immunome Inc was a trade of 18,864 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 18,864 | 18,864 | - | - | Director Stock Option (right to buy) | |
| Immunome Inc | Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) | |
| Immunome Inc | Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 15 Jan 2023 | 8,750 | 406,147 | - | 4 | 35,000 | Common Stock |
| Immunome Inc | Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Philip Wagenheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Philip Wagenheim | Director | Purchase of securities on an exchange or from another person at price $ 18.35 per share. | 24 May 2021 | 13,500 | 397,397 | - | 18.4 | 247,725 | Common Stock |